PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,210 | -85.5% | 15,289 | -80.5% | 0.01% | -86.0% |
| Q2 2023 | $276,929 | +9.8% | 78,450 | -3.9% | 0.05% | -5.7% |
| Q1 2023 | $252,203 | -36.8% | 81,619 | -13.5% | 0.05% | -37.6% |
| Q4 2022 | $399,122 | +504.7% | 94,355 | +236.3% | 0.08% | +431.2% |
| Q3 2022 | $66,000 | -35.9% | 28,056 | -22.3% | 0.02% | -61.9% |
| Q2 2022 | $103,000 | -41.5% | 36,130 | -41.0% | 0.04% | -45.5% |
| Q1 2022 | $176,000 | +91.3% | 61,218 | +102.0% | 0.08% | +48.1% |
| Q4 2021 | $92,000 | -36.1% | 30,308 | +93.0% | 0.05% | +6.1% |
| Q2 2021 | $144,000 | – | 15,705 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |